Intellia Therapeutics, Inc. 8-K

Accession 0000950170-24-044424

Filing information

CIK: 0001652130
Report date: 2024-04-10
Filing date: 2024-04-15
Form: 8-K
Primary document: ntla-20240410.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.